201 related articles for article (PubMed ID: 25585568)
1. NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.
Gordon CA; Gulzar ZG; Brooks JD
Prostate; 2015 Apr; 75(5):517-26. PubMed ID: 25585568
[TBL] [Abstract][Full Text] [Related]
2. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
[TBL] [Abstract][Full Text] [Related]
4. NUSAP1 promotes invasion and metastasis of prostate cancer.
Gordon CA; Gong X; Ganesh D; Brooks JD
Oncotarget; 2017 May; 8(18):29935-29950. PubMed ID: 28404898
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.
Gulzar ZG; McKenney JK; Brooks JD
Oncogene; 2013 Jan; 32(1):70-7. PubMed ID: 22349817
[TBL] [Abstract][Full Text] [Related]
6. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
Xu Z; Wang Y; Xiong J; Cui F; Wang L; Peng H
J Cell Physiol; 2020 Apr; 235(4):3886-3893. PubMed ID: 31603257
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
8. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
9. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
[TBL] [Abstract][Full Text] [Related]
10. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells.
Tsui KH; Chang YL; Feng TH; Chung LC; Lee TY; Chang PL; Juang HH
J Mol Endocrinol; 2012 Oct; 49(2):153-63. PubMed ID: 22872134
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
13. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
15. E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.
Ren Z; Kang W; Wang L; Sun B; Ma J; Zheng C; Sun J; Tian Z; Yang X; Xiao W
Mol Cancer; 2014 Apr; 13():84. PubMed ID: 24742333
[TBL] [Abstract][Full Text] [Related]
16. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer.
Han G; Wei Z; Cui H; Zhang W; Wei X; Lu Z; Bai X
Exp Cell Res; 2018 Jun; 367(2):216-221. PubMed ID: 29608915
[TBL] [Abstract][Full Text] [Related]
17. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
Kang DW; Lee SW; Hwang WC; Lee BH; Choi YS; Suh YA; Choi KY; Min DS
Cancer Res; 2017 Jan; 77(1):142-152. PubMed ID: 27793841
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway.
Wu X; Xu B; Yang C; Wang W; Zhong D; Zhao Z; He L; Hu Y; Jiang L; Li J; Song L; Zhang W
J Exp Clin Cancer Res; 2017 Sep; 36(1):127. PubMed ID: 28899410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
